© 2020 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
Atopic Dermatitis
Looking at atopic dermatitis treatment options
July 24, 2020
Atopic dermatitis treatment has dramatically changed over the years. Here’s a look at the current options.
FDA approves dupilumab for atopic dermatitis treatment in pediatrics
May 26, 2020
The US Food and Drug Administration has approved dupilumab (Dupixent, Sanofi and Regeneron) for the treatment of moderate-to-severe atopic dermatitis in children aged 6 to 11 years.
Postpartum depression linked to atopic dermatitis in children
February 06, 2020
Postpartum depression has a number of profound effects. A new study indicates that postpartum depression could increase the risk of atopic dermatitis, especially at ages 5 and 9 years.